Analysts Rahman and McCarthy hold a conference call with CFO Zante on April 30 hosted by Maxim Group.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VKTX:
- Promising Developments and Strong Financial Position Bolster Buy Rating for Viking Therapeutics
- Viking Therapeutics: Promising Pipeline and Strategic Execution Drive Buy Rating
- Viking Therapeutics price target lowered to $85 from $96 at B. Riley
- Viking Therapeutics: Strong Financials and Promising VK2735 Program Drive Buy Rating
- Viking Therapeutics Advances Clinical Pipeline in Q1 2025